Clinical Trial Update: A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1b/2a trial of DKN-01 as monotherapy or with docetaxel in advanced prostate cancer with elevated DKK1 was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DKN-01 (dkn-01)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: NYU Langone Health | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-12-18